| Name | Title | Contact Details |
|---|
ACRIA is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Since 1997, Network Health has been committed of improving the health and well-being of its members and their diverse communities. Today the company provides high-quality, comprehensive health care coverage to more than 160,000 residents who qualify for Mass Health and Commonwealth Care in more than 300 cities and towns across Massachusetts.
FLAVORx, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Bethesda, MD. To find more information about FLAVORx, Inc., please visit www.flavorx.com
Valencell develops performance biometric sensor technology and provides this patent-protected technology to consumer electronics manufacturers, wearable and hearable device makers, sports and fitness brands, medical device makers, and gaming companies for integration into their products.
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.